Tuesday, February 09, 2010
Seroxat linked to breast cancer deaths
I'd like to personally thank the MHRA for allowing a drug that is known to cause severe withdrawal reactions, suicidal ideation, birth defects and now breast cancer on to the market.
Benefits outweigh the risks?
This from today's Daily Mail
Women taking a popular anti-depressant at the same time as a drug used to stop breast cancer recurring are more likely to die from the disease, doctors warn.
Researchers have found that the anti-depressant Seroxat can interfere with tamoxifen, which is prescribed to thousands of breast cancer survivors for five years at a time.
The findings have major implications because many of these women also suffer from depression, with up to one in four affected.
However, other anti-depressants did not have the same effect.
A study led by a team from the Sunnybrook Health Sciences Centre and the University of Toronto in Canada looked at 2,430 women aged 66 and over who were being treated between 1993 and 2005.
All were taking tamoxifen and one of five anti-depressants, including Seroxat, which was the most commonly prescribed. Seroxat is also known as paroxetine.
Over the next 2.4 years, 374 died from breast cancer. Analysis showed that those taking Seroxat were far more likely to die from breast cancer and slightly more likely to die from any other cause, compared with women not on the drug.
The researchers found that if patients took Seroxat for 25 per cent of the time they were on tamoxifen, they were 24 per cent more likely to die from breast cancer.
Full shocking story HERE
How others are reporting this shocking news:
Women taking the antidepressant paroxetine (brand name Seroxat) alongside
tamoxifen for breast cancer were more likely to die from the disease than women
on other antidepressants, a study found.
UK Press Association -
Meg McArthur, from Breakthrough Breast Cancer, said: "This research is welcome
because it gives an insight into how the effectiveness of tamoxifen could be
influenced by taking antidepressants. Tamoxifen remains a beneficial treatment
for breast cancer and as several antidepressants are available doctors should be
able to find the right combination for patients.
Researchers from the University of Toronto looked at 2,430 women aged over 66
who were taking tamoxifen and one of five anti-depressants. Those taking Seroxat
were more likely to die from breast cancer and were slightly more likely to die
from any other cause compared with women not on Seroxat.
Benefits outweigh the risks huh?
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
About the Author :
Bob Fiddaman has been writing about the dangers of antidepressants since 2006. In 2011 he was presented with two human rights awards from the Citizens Commission on Human Rights.
Labels: bobfiddaman, Fiddaman, fiddaman blog, Marketing, Paroxetine, Paxil, Seroxat, Seroxat Sufferers, Seroxat Sufferers Stand Up and be Counted, THE EVIDENCE HOWEVER IS CLEAR